Michael Jeffers
Inventor
Stats
- 7 US patents issued
- 22 US Applications filed
- most recent filing
This is official USPTO record data
Details
- 7 US Patents Issued
- 22 US Applications Filed
- 209 Total Citation Count
- Jul 25, 2018 Most Recent Filing
- Jul 3, 2000 Earliest Filing
Work History
| Patent Owner | Applications Filed | Year |
|---|---|---|
| CURAGEN CORPORATION | 2
3 2 4 | 2000
2001 2002 2004 |
| CELLDEX THERAPEUTICS, INC. | 2
2 1 | 2011
2012 2017 |
| Amgen Fremont Inc. | 2
2 2 1 | 2004
2011 2012 2017 |
| BAYER HEALTHCARE PHARMACEUTICALS INC. | 2
| 2016
|
| BAYER PHARMA AKTIENGESELLSCHAFT | 1
2 | 2013
2016 |
| MICROSOFT TECHNOLOGY LICENSING, LLC | 1
1 | 2011
2014 |
Inventor Addresses
| Address | Duration |
|---|---|
| Boston, MA, US | Mar 28, 13 - Apr 28, 20 |
| Branford, CT | May 16, 02 - Aug 07, 07 |
| Branford, CT, US | Oct 02, 03 - Aug 03, 17 |
| Ridgewood, NJ, US | Sep 24, 15 - Apr 22, 21 |
Technology Profile
| Technology | Matters | |
|---|---|---|
| A61K: | PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES | 18 |
| A61P: | THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS | 4 |
| C07H: | SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS | 4 |
Patents / Publication
| Patents / Publication # | Year of Publication / Issued | Title | Citations |
|---|---|---|---|
| 2021/0113,598 | 2021 | Combination of MIDH1 Inhibitors and DNA Hypomethylating Agents (HMA) | 0 |
| 10635540 | 2020 | Modern document save and synchronization status | 0 |
| 10406162 | 2019 | Substituted 2,3-dihydroimidazo[1,2-C]quinazoline-containing combinations | 3 |
| 2018/0055,851 | 2018 | SUBSTITUTED 2,3-DIHYDROIMIDAZO[1,2-C]QUINAZOLINE-CONTAINING COMBINATIONS | 9 |
| 2018/0042,929 | 2018 | USE OF SUBSTITUTED 2,3-DIHYDROIMIDAZO[1,2-C]QUINAZOLINES | 12 |
We are sorry but your current selection exceeds the maximum number of portfolios (0) for this membership level.
>
Upgrade to our Level for up to -1 portfolios!.